With proper testing regulations, consumer health can be protected and a prosperous, strong and trustworthy cannabis industry will be created.
This article originally appeared on Cannabis.net and has been reposted with permission.
With the increasing demand for legal cannabis and heightened participation of various states, the need for comprehensive and rigorous testing solutions has become vital. Considering a lot of individuals use cannabis products for medical purposes, they should not have to worry about falling ill from consuming pathogenic infested cannabis products.
This concern is most especially true for consumers with autoimmune disorders as the negative impact of consuming contaminated hemp is fatal. While there could be federal criteria for pathogen testing prerequisite, that can’t happen just yet as cannabis isn’t legal at the feral level. To this end, the tasks have called on state regulators, legislators, and maintenance operators to safeguard consumers’ health via the implementation of more rigorous testing.
Looking at the environmental conditions needed for cannabis to grow — light, heat, soil, and humidity, these same sets of conditions also allow the prolific growth of pathogens. These pathogens are so present that even when cannabis farmers take all the necessary sanitation protocols, contamination is still very possible.
This is why cannabis firms need to be very proactive and hyper-vigilant about testing rather than reactive. At the moment, several states are lacking testing regulations which is quite alarming, and considering the competitiveness in the cannabis industry, many companies have been established within a short time.
Unfortunately, many of these cannabis firms are unscrupulous actors that rode into the industry courtesy of loose testing regulations. Many of the businesses were established to earn quick cash even to the detriment of consumers’ health. To break this vicious cycle, then there’s a need to establish more rigorous enforcement and regulations.
What many cannabis firms don’t realize is that while loose testing regulations might help them make money in the short term, more damage will be done in the long term. The long-term effect of this loose testing regulation will carry major economic consequences and damage to the industry. Above all, death or injury to patients and customers. If recalls of cannabis products should happen based on the mentioned instances, it could be the beginning of the end.
If recalls should happen, the media will be all over it, and opponents of cannabis legalization will have a reason to back their claims. To win the public hearts and the opposition’s minds, then the need for a safe product is paramount. Hence, cannabis will be labeled as a risky herb.
Taking a closer look, the irony at play is evident. While a sense of cannabis regulation at the federal level increases the risk of cannabis contamination, recalls can be used by the opposition to justify their claims to keeping the plant illegal. Notwithstanding, sooner rather than later federal legalization of cannabis will happen. When that happens, federal agents will be able to regulate and effectively test cannabis with cGMP effectively required